Healthcare Finance: The Centers for Medicare and Medicaid Services is now covering Food and Drug Administration approved or cleared laboratory diagnostic tests using Next Generation Sequencing for patients with inherited ovarian or breast cancer.
As a result of the decision, more Medicare patients will have access to Next Generation Sequencing in managing other types of inherited cancers to reduce mortality and improve health outcomes.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now